Skip to main content
. Author manuscript; available in PMC: 2009 Jun 22.
Published in final edited form as: J Immunol. 2008 May 15;180(10):6467–6471. doi: 10.4049/jimmunol.180.10.6467

Figure 1. Phenotypic characterization and distribution of normal C57BL/6 mouse CD4+CD25+TNFR2+ Tregs.

Figure 1

(A) Splenocytes were stained with anti CD4 and TNFR2 Abs and analyzed by FACS. (B) Splenocytes were stained with anti CD3, CD4, CD25 and TNFR2 Abs. The expression of TNFR2 by CD4+CD25+ cells (grey histogram) and CD4+CD25 cells (solid line histogram) was analyzed by FACS, gating on CD3+ cells. Dashed line represents isotype control. (C) Splenocytes were stained with anti CD3, CD4, CD25 and TNFR2. Expression of CD25 and TNFR2 was analyzed with FACS by gating on CD3+CD4+ cells. (D) Splenocytes were stained with anti CD4, CD25, TNFR2 and CD45RB, or CD62L, or CD44, or CD69, or CD103, or GITR, or CTLA-4, or FoxP3 Abs. CTLA-4 and FoxP3 were stained intracellularly. Expression of phenotypic markers was analyzed with FACS by gating on indicated CD4 subsets. (E) Cells from indicated lymphoid tissues and peripheral blood were stained with anti CD3 (or CD8 for thymocytes), CD4, CD25 and TNFR2 Abs. The percentage of TNFR2+ cells was analyzed with FACS by gating on CD3+CD4+CD25+ population (except for thymocytes which were gated on CD8CD4+CD25+ cells). Error bars indicate SE derived from 3 mice (n=3). Numbers in the quadrants represent percentage of positive staining cells (%).The numbers in the histograms show percentage of positive cells (%) and MFI. Data shown are representatives of at least 3 separate experiments with similar results.

HHS Vulnerability Disclosure